Adenosine.

Caffeine is a competitive antagonist at A1 and A2A adenosine receptors, which is the whole basis of its alerting effect. Taken together the two work against each other at the same binding site.

Methylliberine is a methylxanthine-type purine alkaloid described as blocking adenosine receptors in the same way caffeine does. Its action opposes adenosine signalling at the receptor.

Ribose-5-phosphate is the sugar backbone of adenine nucleotides and the rate-limiting input to de novo purine synthesis. Supplying ribose supports rebuilding the adenine nucleotide pool that adenosine belongs to.

ATP is biologically active as the magnesium chelate, and every kinase that handles adenine nucleotides binds Mg-ATP rather than free ATP. Magnesium status is inseparable from adenine nucleotide handling.

NAD is a dinucleotide carrying an adenosine monophosphate half, and its synthesis consumes ATP at the NMN adenylyltransferase step. The adenine nucleotide pool and the NAD pool draw on each other.

Phosphocreatine donates its phosphate to ADP to regenerate ATP during rapid work, which keeps the adenine nucleotide pool from degrading toward adenosine. The two sit on the same energy buffer axis.

The adenosyl group on this B12 form is transferred directly from ATP by adenosyltransferase. The cofactor is built out of the adenine nucleotide pool.

Adenosine deaminase converts adenosine directly to inosine, so the two sit one enzymatic step apart on the same salvage route. Taking either one feeds the shared purine pool rather than acting on separate pathways. The direction of flow depends on deaminase activity, which varies by tissue. This is pathway relatedness, not a demonstrated additive effect in people.

After SAM-e donates a methyl group it becomes S-adenosylhomocysteine, which is hydrolysed to adenosine plus homocysteine. Because that hydrolysis is reversible and thermodynamically unfavourable in the forward direction, adenosine that is not cleared slows the step. The two compounds are therefore linked at a single enzyme rather than acting independently. Clearance of both products is what keeps normal methylation flux moving.

Betaine donates a methyl group to homocysteine, the other product of the reaction that releases adenosine. Pulling homocysteine forward keeps the SAH hydrolysis step moving in the direction that generates adenosine. This is textbook pathway coupling rather than a tested combination. Individual methylation capacity varies with folate and B12 status.

Methylfolate feeds the methionine synthase route that consumes homocysteine, the co-product of the reaction releasing adenosine. Adequate folate status keeps that arm of the cycle turning. The relationship is upstream cofactor supply, not a direct effect on adenosine receptors. No combination trial is being described.

Methionine synthase needs methylcobalamin to move a methyl group from folate onto homocysteine. That step sits in the same cycle that produces adenosine from S-adenosylhomocysteine. Cobalamin status therefore shapes the flux around adenosine release without acting on adenosine itself. This is settled cofactor biochemistry.

Methylxanthines including caffeine occupy adenosine A1 and A2A receptors without activating them, so they blunt adenosine signalling at those sites. Green tea extracts vary widely in caffeine content, and decaffeinated preparations carry little. Anyone pairing the two should regard the interaction as opposing rather than additive. The competition is at the receptor, not at absorption.

Adenosine builds up in the brain during waking and is one arm of homeostatic sleep pressure. Melatonin carries the circadian timing signal instead. The two act on different control systems that both point toward sleep onset, so their effects on drowsiness can stack. Combined use has not been characterised in a trial and the additive drowsiness is the point to watch.

A2A receptor activation raises cyclic AMP in vascular smooth muscle, while citrulline supports arginine availability for nitric oxide synthase and cyclic GMP signalling. The two arrive at normal vasodilation by separate messengers, so the effects can be additive in principle. This is a mechanistic overlap, not a measured outcome from a combination study. Blood pressure effects of the pair have not been characterised.

Nitrate from beetroot is reduced by oral bacteria to nitrite and then to nitric oxide, supporting normal vessel relaxation. Adenosine relaxes the same tissue through A2A and cyclic AMP. Two independent routes to the same physiology can add up, and the combination has not been formally studied. Effects on blood pressure would be worth monitoring rather than assumed.